| HOME >> BIOLOGY >> TECHNOLOGY |
10. FOCUS ON SELECT GLOBAL PLAYERS 98
Aduro BioTech (USA) 98
Arrowhead Research Corporation (USA) 98
Calando Pharmaceuticals, Inc. (USA) 98
Agilent Technologies Inc (USA) 99
Asklepios BioPharmaceutical Inc (USA) 99
Biosante Phosphate Pharmaceuticals, Inc. (USA) 99
Celgene Corporation (USA) 99
Abraxis Bioscience, Inc (USA) 100
Elan Pharmaceuticals, Inc. (USA) 100
Flamel Technologies, Inc. (France) 100
Gilead Sciences Inc (USA) 101
Life Technologies Corporation (USA) 101
BioTrove, Inc. (USA) 101
NanoBio Corporation (USA) 101
Nanogen, Inc. (US) 102
Nanophase Technologies Corporation (USA) 102
pSivida Ltd (Australia) 103
Sigma Aldrich Company (USA) 103
Starpharma Holdings Ltd. (Australia) 103
Dendritic Nanotechnologies, Inc. (USA) 104
SkyePharma Pharmaceuticals (UK) 104
Unidym, Inc. (USA) 105
Zyvex Instruments LLC (USA) 105
11. GLOBAL MARKET PERSPECTIVE 106
Table 13: World Recent Past, Current & Future Analysis for
Nanobiotechnology by Geographic Region - USA, Japan, Europe,
and Rest of World Markets Independently Analyzed with Annual
Revenue Figures in US$ Million for Years 2007 through 2015
(includes corresponding Graph/Chart) 106
Table 14: World Historic Review for Nanobiotechnology by
Geographic Region - USA, Japan, Europe, and Rest of World
Markets Independently Analyzed with Annual Revenue Figures in
US$ Million for Years 2001 through 2006 (includes
corresponding Graph/Chart) 107
Table 15: World 13-Year Perspective for Nanobiotechnology by
Geographic Region - Percentage Breakdown of Revenues for USA,
Japan, Europe, and Rest of World for Years 2003, 2009 & 2015
(includes corresponding Graph/Chart) 108
Analytics by Product Segment 109
Table 16: World Recent
'/>"/>
| SOURCE Reportlinker Copyright©2010 PR Newswire. All rights reserved |